Welcome to Tech in Asia’s daily newsletter, your essential dose of Asia’s tech and startup buzz. Not on the mailing list? Register here. Got a story tip? Send it to editors@techinasia.com.
Hello there,
Ever watched the movie Gattaca?
As someone who enjoys science fiction, I’ve always been fascinated by the concept of using technology to alter our very biology.Traveling through time or to other galaxies might not be possible any time soon, but genetic engineering and other similar technologies? Those seem a little more within reach.
Think about all the diseases we could cure and how many lives could be improved. To that end, it’s nice to see not just one but two biotechnology startups top our fundraising list this week.
You can find all other important investment deals that happened in the last few days in our weekly funding news wrap-up.
Let’s dive into the biggest deals and M&As that recently took place.
— Jonathan
The biggest deals by country
🇨🇳 Inxmed, a Chinese biotech company, has raised US$34 million in series C money from Chengxiang Capital, Ennovation Ventures, Fosun Health Capital, Kunlun Capita, and Proxima Ventures.
🇦🇺 Australia’s Vaxxas is a biotech startup that raised US$32 million in a series D round, with investments from Hostplus, LGT Crestone, OneVentures, and Sprim Global Investments. The firm also secured an additional US$25.9 million in debt facilities.
🇮🇳 TransBnk, a banking platform, from India, has netted US$25 million from its series B round from investors such as 8i Ventures, Accion Venture Lab, Arkam Ventures, Bessemer Venture Partners, Fundamentum, and GMO Venture Partners.
🇦🇪 Holo is an online mortgage platform based in the United Arab Emirates. The company bagged US$22 million in series A money from Dubai Future District Fund, Impact46, MoreThan Capital, Mubadala Investment Company, Oryx Fund, Rua Growth Fund, as well as Anb Capital.
Behind the Glasswall
Defying the odds, redefining the future
Lists of most active investors in the region
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
